UPDATE: Horizon Therapeutics (HZNP) PT Lowered to $90 at Oppenheimer
Tweet Send to a Friend
(Updated - September 12, 2022 1:35 PM EDT)
Oppenheimer analyst Leland Gershell lowered the price target on Horizon Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Leland Gershell lowered the price target on Horizon Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
